Monument Therapeutics

Monument Therapeutics

Biotechnology Research Macclesfield, Cheshire East, United Kingdom 8 employees
Employees
8
Contacts
2
Emails
2
Phones
1

Monument Therapeutics Overview

Headquarters
Macclesfield, Cheshire East, United Kingdom
Website
monumenttx.com
Industry
Biotechnology Research
Employees
8
Funding
1.1M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Monument Therapeutics

Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience drug development to provide a precision medicine approach in clinical areas of high unmet need. Contact us to learn more about our company and solutions.

Monument Therapeutics Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

Monument Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Sheryl Caswell
Email Phone
Robert S. Radie Chairman of the Board and Chief Officer
View
Jenny Barnett
View
Dr Kiri Granger Chief Scientific Officer, Co-founder
Email

Employees by Management Level

Executive 2 profiles
Manager 1 profile

Department Contact Coverage

Department Contacts Email Phone
Operations 1 1 0

Compare Similar Companies to Monument Therapeutics